tiprankstipranks
ACADIA Pharmaceuticals (MX:ACAD)
:ACAD
Mexico Market
ACAD
ACADIA Pharmaceuticals
RESEARCH TOOLSreports

ACADIA Pharmaceuticals (ACAD) Ratios

0 Followers

ACADIA Pharmaceuticals Ratios

MX:ACAD's free cash flow for Q2 2026 was $0.91. For the 2026 fiscal year, MX:ACAD's free cash flow was decreased by $ and operating cash flow was $0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.39 3.83 2.38 2.42 4.04
Quick Ratio
 3.30 3.71 2.32 2.28 3.99
Cash Ratio
 1.07 0.64 0.81 0.74 0.91
Solvency Ratio
 0.90 1.20 0.53 -0.18 -1.14
Operating Cash Flow Ratio
 0.54 0.40 0.40 0.07 -0.91
Short-Term Operating Cash Flow Coverage
 0.00 9.44 0.00 1.78 0.00
Net Current Asset Value
$ 788.25M$ 725.31M$ 483.36M$ 298.92M$ 320.54M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.03 0.04 0.08 0.11
Debt-to-Equity Ratio
 0.06 0.04 0.07 0.13 0.15
Debt-to-Capital Ratio
 0.05 0.04 0.07 0.12 0.13
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.33 1.27 1.62 1.73 1.47
Debt Service Coverage Ratio
 0.00 34.62 0.00 -8.30 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 0.00 <0.01 0.00 <0.01 0.00
Interest Debt Per Share
 0.43 0.31 0.31 0.35 0.38
Net Debt to EBITDA
 -2.68 -0.83 -2.67 1.94 0.24
Profitability Margins
Gross Profit Margin
91.13%91.69%91.46%93.70%98.03%
EBIT Margin
9.14%12.96%8.80%-10.10%-43.23%
EBITDA Margin
10.20%14.06%10.46%-9.34%-42.84%
Operating Profit Margin
7.59%9.78%24.10%-10.10%-43.23%
Pretax Profit Margin
10.66%12.96%26.94%-7.03%-41.27%
Net Profit Margin
33.42%36.49%23.64%-8.44%-41.76%
Continuous Operations Profit Margin
33.42%36.49%23.64%-8.44%-41.76%
Net Income Per EBT
313.50%281.49%87.75%120.08%101.19%
EBT Per EBIT
140.53%132.53%111.82%69.55%95.46%
Return on Assets (ROA)
21.83%25.00%19.07%-8.18%-36.74%
Return on Equity (ROE)
32.39%31.86%30.90%-14.19%-53.94%
Return on Capital Employed (ROCE)
6.25%8.14%29.11%-14.83%-48.38%
Return on Invested Capital (ROIC)
6.19%8.07%25.22%-14.56%-47.42%
Return on Tangible Assets
23.21%26.87%21.20%-8.97%-36.74%
Earnings Yield
7.91%8.64%7.45%-1.19%-8.39%
Efficiency Ratios
Receivables Turnover
 6.85 7.23 9.15 7.10 8.20
Payables Turnover
 2.27 8.16 5.05 2.61 0.80
Inventory Turnover
 3.12 2.57 3.73 1.28 1.53
Fixed Asset Turnover
 13.16 19.53 18.86 12.86 8.40
Asset Turnover
 0.65 0.69 0.81 0.97 0.88
Working Capital Turnover Ratio
 1.38 1.61 2.12 1.95 1.14
Cash Conversion Cycle
 9.24 147.97 65.57 197.30 -174.86
Days of Sales Outstanding
 53.32 50.49 39.90 51.43 44.51
Days of Inventory Outstanding
 117.01 142.19 97.89 285.89 238.26
Days of Payables Outstanding
 161.09 44.72 72.21 140.02 457.63
Operating Cycle
 170.33 192.68 137.79 337.31 282.77
Cash Flow Ratios
Operating Cash Flow Per Share
 1.13 0.65 0.95 0.10 -0.71
Free Cash Flow Per Share
 1.02 0.62 0.95 -0.14 -0.71
CapEx Per Share
 0.12 0.03 <0.01 0.24 0.00
Free Cash Flow to Operating Cash Flow
 0.90 0.96 1.00 -1.40 1.00
Dividend Paid and CapEx Coverage Ratio
 9.76 23.42 301.57 0.42 0.00
Capital Expenditure Coverage Ratio
 9.76 23.42 301.57 0.42 0.00
Operating Cash Flow Coverage Ratio
 2.63 2.10 3.03 0.29 -1.84
Operating Cash Flow to Sales Ratio
 0.17 0.10 0.16 0.02 -0.22
Free Cash Flow Yield
3.63%2.32%5.17%-0.46%-4.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.45 11.51 13.39 -83.69 -11.92
Price-to-Sales (P/S) Ratio
 4.21 4.22 3.17 7.06 4.98
Price-to-Book (P/B) Ratio
 3.68 3.69 4.15 11.88 6.43
Price-to-Free Cash Flow (P/FCF) Ratio
 27.51 43.02 19.34 -219.68 -22.57
Price-to-Operating Cash Flow Ratio
 24.75 41.18 19.28 307.10 -22.57
Price-to-Earnings Growth (PEG) Ratio
 0.18 0.17 -0.03 1.16 -0.43
Price-to-Fair Value
 3.68 3.69 4.15 11.88 6.43
Enterprise Value Multiple
 38.64 29.19 27.69 -73.68 -11.38
Enterprise Value
 4.49B 4.40B 2.77B 5.00B 2.52B
EV to EBITDA
 38.64 29.19 27.69 -73.68 -11.38
EV to Sales
 3.94 4.10 2.90 6.88 4.87
EV to Free Cash Flow
 25.73 41.82 17.64 -214.05 -22.11
EV to Operating Cash Flow
 23.09 40.04 17.58 299.23 -22.11
Tangible Book Value Per Share
 7.01 6.61 3.70 2.24 2.48
Shareholders’ Equity Per Share
 7.61 7.25 4.42 2.64 2.48
Tax and Other Ratios
Effective Tax Rate
 -2.13 -1.81 0.12 -0.20 -0.01
Revenue Per Share
 6.64 6.33 5.78 4.43 3.20
Net Income Per Share
 2.22 2.31 1.37 -0.37 -1.34
Tax Burden
 3.13 2.81 0.88 1.20 1.01
Interest Burden
 1.17 1.00 3.06 0.70 0.95
Research & Development to Revenue
 0.29 0.31 0.32 0.48 0.70
SG&A to Revenue
 0.54 0.51 0.51 0.54 0.00
Stock-Based Compensation to Revenue
 0.05 0.00 0.07 0.09 0.13
Income Quality
 0.51 0.28 0.70 -0.27 0.53
Currency in USD